Синдром последствий интенсивной терапии

Синдром последствий интенсивной терапии (PICS-CCI) возникает у тех пациентов реанимационных отделений, которые выжили после перенесенного критического состояния, если длительность лечения в таких отделениях превышала более 14 дней и сопровождалась органной дисфункцией. Следует отметить, что помимо крайне низких показателей долгосрочной реабилитации, у них также значительно снижены физические функции, связанные со здоровьем по сравнению с другими пациентами.

Цель работы: проанализировать данные литературных источников, затрагивающих вопросы таких хронических критических состояний, как синдром последствий интенсивной терапии; подчеркнуть необходимость дальнейшего мультидисциплинарного подхода в изучении данного феномена, а также в ведении и лечении такой категории пациентов, что будет способствовать увеличению процента выживаемости и улучшению качества жизни пациентов с PICS-CCI.

1. Парфёнов, А. Л. Хроническое критическое заболевание: современные аспекты проблемы (обзор) / А. Л. Парфёнов, В. П. Разживин, М. В. Петрова // СТМ. 2022. Т. 14, № 3. С. 70–83.

2. R osenthal, M. D. Chronic Critical illness and PICS Nutritional Strategies / M. D. Rosenthal, E. L. Vanzant, F. A. Moore // Journal of Clinical Medicine. 2021. № 10. Mode of access: https://doi.org/10.3390/jcm10112294. Date of access: 10.04.2025.

3. Rosenthal, M. D. Persistent, Immunosuppression, Inflammation, Catabolism Syndrome and Diaphragmatic Dysfunction / M. D. Rosenthal [et al.] // Current Pulmonology Reports. 2017. № 6. P. 54–57.

4. Hawkins, R. B. Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome / R. B. Hawkins [et al.] // Frontiers in Immunology. 2018. № 9. Mode of access: https://doi/10.3389/fimmu.2018.01511. Date of access: 10.04.2025.

5. Horn, D. L. Persistent metabolomic alterations characterize chronic critical illness after severe trauma / D. L. Horn [et al.] // Journal of Trauma and Acute Care Surgery. 2021. Vol. 90, № 1. P. 35–45.

6. Rosenthal, M. D. Chronic Critical Illness Patients Fail to Respond to Current Evidence-Based Intensive Care Nutrition Secondarily to Persistent Inflammation, Immunosuppression, and Catabolic Syndrome / M. D. Rosenthal [et al.] // JPEN. 2020. Vol. 44, № 7. P. 1237–1249.

7. Mikkelsen, M. E. Post-intensive care syndrome (PICS) in adults: Clinical features and diagnostic evaluation [Electronic resource] / M. E. Mikkelsen, G. Netzer, T. Iwashyna // UpToDate. Mode of access: https://www.uptodate.com/contents/post-intensivecare-syndrome-pics-in-adults-clinical-featuresand-diagnostic-evaluation/print. Date of access: 10.04.2025.

8. Marra, A. Cooccurrence of Post-Intensive Care Syndrome Problems Among 406 Survivors of Critical illness / A. Marra [et al.] // Critical Care Medicine. 2018. Vol. 46, № 9. P. 1393–1401.

9. Белкин, А. А. Синдром последствий интенсивной терапии (ПИТ-синдром) / А. А. Белкин // Вестник интенсивной терапии имени А. И. Салтанова. 2018. № 2. С. 12–23.

10. Marshall, J. C. Critical illness is an iatrogenic disorder / J. C. Marshall // Critical Care Medicine. 2010. Vol. 38, № 10. –P. 582–589.

11. Андрейченко, С. А. Синдром приобретенной в ОРИТ слабости у больных с дыхательной недостаточностью / С. А. Андрейченко [и др.] // Клиническая практика. 2021. Т. 12, № 2. С. 5–13.

12. Mankowski R. T. Pathophysiology and Treatment Strategies of Acute Myopathy and Muscle Wasting after Sepsis / R. T. Mankowski [et al.] // Journal of Clinical Medicine. 2021. Mode of access: https://doi.org/10.3390/jcm10091874. Date of access 10.04.2025.

13. He, X. Post intensive care syndrome: A review of clinical symptoms, evaluation, intervention / X. He [et al.] // Heliyon. 2024. № 10. Mode of access: https://doi.org/10.1016/j.heliyon.2024.e31278. Date of access: 10.04.2025.

14. Плотников, Г. П. Полинейромиопатия критических состояний (обзор литературы) / Г. П. Плотников [и др.] // Вестник анестезиологии и реаниматологии. 2023. Т. 20, № 5. С. 76–83.

15. Panahi, A. The Prevalence and Outcome of Intensive Care Unit Acquired Weakness (ICUAW) / A. Panahi [et al.] // Tanaffos. 2020. Vol. 19, № 3. P. 250–255.

16. Belkin, A. A. , Alasheev, A. M. Correlation links between the length of peripheral nerves and the rate of their involvement into critical illness polyneuropathy (CIMP) / A. A. Belkin, A. M. Alasheev // European Journal of Anesthesiology. 2005. № 22. P. 15–16.

17. Stevens, R. D. A framework for diagnosing and classifying intensive care unit-acquired weakness / R. D. Stevens [et al.] // Critical Care Medicine. 2009. Vol. 37, № 10. P. 299–308.

18. Vollenweider, R. Passive motion of the lower extremities in sedated and ventilated patients in the ICU a systematic review of early effects and replicability of Interventions / R. Vollenweider [et al.] // PLoS One. 2022. Vol. 17, № 5. Mode of access https://doi/10.1371/journal.pone.0267255. Date of access: 10.04.2025.

19. Liu, Y. The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy / Y. Liu [et al.] // Frontiers in Immunology. 2022. Vol. 13. Mode of access: https://doi/10.3389/fimmu.2022.1035709. Date of access: 10.04.2025.

20. Latronico, N. The ICM research agenda on intensive care unit-acquired weakness / N. Latronico [et al.] // Intensive Care Medicine. 2017. Vol. 43, № 9. P. 1270–1281.

21. Brodsky, M. B. Recovery of Dysphagia Symptoms after Oral Endotracheal Intubation in ARDS Survivors: A 5-Year Longitudinal Study / M. B. Brodsky [et al] // Annals of the American Thoracic Society. 2017. Vol.14, № 3. P. 376–383.

22. Lynch, Y. T. The accuracy of the bed side swallowing evaluation for detecting aspiration in survivors of acute respiratory failure / Y. T. Lynch [et al.] // Journal of Critical Care. 2017. № 39. P. 143–148.

23. Kim, M. J. Associations between prolonged intubation and developing post-extubation dysphagia and aspiration pneumonia in non-neurologic critically ill patients / M. J. Kim [et al.] // Annals of Rehabilitation Medicine. 2015. Vol. 39, № 5. P. 763–771.

24. Malandraki, G. A. Postextubation Dysphagia in Critical Patients: A First Report from the Largest Step-Down Intensive Care Unit in Greece / G. A. Malandraki [et al.] // American Journal of Speech-Language Pathology. 2016. Vol.25, № 2. P. 150–156.

25. Inoue, S. Post-intensive care syndrome: its pathophysiology, prevention, and future directions / S. Inoue [et al.] // Acute Medicine & Surgery. 2019. № 6. P. 233–246.

26. Sakusic, A. Potentially Modifiable Risk Factors for Long-Term Cognitive Impairment After Critical Illness: A Systematic Review / A. Sakusic [et al.] // Mayo Clinic Proceedings. 2018. Vol. 93, № 1. P. 68–82.

27. Kim, I-Y. The anabolic response to a meal containing different amounts of protein is not limited by the maximal stimulation of protein synthesis in healthy young adults / I-Y. Kim [et al.] // American journal of physiology. Endocrinology and metabolism. –2016. № 310. P. 73–80.

28. Landi, F. Muscle loss: the new malnutrition challenge in clinical practice / F. Landi [et al] // American journal of Clinical Nutrition. 2019. Vol. 38, № 5. P.2113–2120.

29. McClave, S. A. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A. S.P. E.N.) / S. A. McClave [et al.] // JPEN. 2016. № 40. P. 159–211.

30. Deutz, N. E ., Wolfe, R. R. Is there a maximal anabolic response to protein intake with a meal? / N. E. Deutz, R. R. Wolfe // American journal of Clinical Nutrition. 2013. № 32. P. 309–313.

31. Hurt, R. T. Summary Points and Consensus Recommendations from the International Protein Summit / R. T. Hurt [et al.] // Nutrition in Clinical Practice. 2017. № 32. P. 142–151.

32. Jones, C. Improving rehabilitation after critical illness through outpatient physiotherapy classes and essential amino acid supplement: a randomized controlled trial / C. Jones [et al.] // Journal of Critical Care. 2015. № 30. P. 901–907.

33. Dijoia, B. D. Dysregulated Immunity and Immunotherapy after Sepsis / B. D. Dijoia [et al.] // Journal of Clinical Medicine. 2021. Vol. 10, № 8. Mode of access: https://doi.org/10.3390/jcm10081742. Date of access: 10.04.2025.

34. Lillian, H. Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS) after Polytrauma: A Rare Syndrome with Major Consequences / H. Lillian [et al.] // Journal of Clinical Medicine. 2020. Vol. 9, № 1. Mode of access: https://doi.org/10.3390/jcm9010191. Date of access: 10.04.2025.

35. Hiroyuki, H. Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabo lism Syndrome and Its Implications for Therapy / H. Hiroyuki [et al.] // Frontiers in Immunology. 2018. № 9. Mode of access: https://doi.org/10.3389/fimmu.2018.00595. Date of access: 10.04.2025.

36. Rosenthal, M. D. Chronic critical illness: application of what we know / M. D. Rosenthal [et al.] // Nutrition in Clinical Practice . 2018. № 33. P. 39–45.

37. Rivera, A. Innate cell communication kickstarts pathogen-specific immunity / A. Rivera [et al.] // Nature Immunology. 2016. № 17. P. 356–363.

38. Fleshner, M ., Crane, C. R. Exosomes, DAMPs and miRNA: Features of stress physiology and immune homeostasis / M. Fleshner, C. R. Crane // Trends Immunology. –2017. № 38. P. 768–776.

39. Kang, J-W. DAMPs activating innate immune responses in sepsis / J-W. Kang [et al.] // Ageing Research Reviews. 2015. № 24. P. 54–65.

40. Maslanik, T. The inflammasome and danger associated molecular patterns (DAMPs) are implicated in cytokine and chemokine responses following stressor exposure / T. Maslanik [et al.] // Brain, Behavior and Immunity. 2013. № 28. P. 54–62.

41. Fleshner, M. Stress-evoked sterile inflammation, danger associated molecular patterns (DAMPs), microbial associated molecular patterns (MAMPs) and the inflammasome / M. Fleshner // Brain, Behavior and Immunity. 2013. № 27. P. 1–7.

42. Hu, Q. Elevated levels of plasma mitochondrial DNA are associated with clinical outcome in intraabdominal infections caused by severe trauma / Q. Hu [et al.] // Surgery Infection. 2017. № 18. P. 610–618.

43. Timmermans, K. Plasma nuclear and mitochondrial DNA levels, and markers of inflammation, shock, and organ damage in patients with septic shock / K. Timmermans[et al.] // Shock. 2016. № 45. P. 607–612.

44. Ingels, C. Soluble RAGE and the RAGE ligands HMGB1 and S100A12 in critical illness: Impact of glycemic control with insulin and relation with clinical outcome / C. Ingels [et al.] // Shock. 2015. № 43. P. 109–116.

45. Achouiti, A. S100A12 and soluble receptor for advanced glycation end products levels during human severe sepsis / A. Achouiti [et al.] // Shock. 2013. № 40. P. 188–194.

46. Picca, A. Circulating Mitochondrial DNA at the Crossroads of Mitochondrial Dysfunction and Inflammation During Aging and Muscle Wasting Disorders / A. Picca [et al.] // REJUVENATION RESEARCH. 2018. Vol. 21, № 4. P. 350–359.

47. Mira, J. C. Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome / J. C. Mira [et al.] // Critical Care Medicine. 2017. № 45. P. 253–262.